ACTIVE

PHARMANN

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

134,6 k €

+28.7% YoY

Gross margin

253,9 k €

+32.4% YoY

Equity

1,2 M €

+13.0% YoY

Workforce

0,0 ETP

What does PHARMANN do?

PHARMANN is a Private limited company incorporated in 2012. Its main activity is: Activities of holding companies. Its registered office is in Kuurne.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0845.887.510

Incorporation

11/05/2012

Legal form

Private limited company

Registered office

Kortrijksestraat 3
8520 Kuurne · FlandreSee on map

Contributed capital

18 550,00 €

Latest accounts

31/03/2025

Average workforce

0,0 ETP

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies

Contacts

2 public details availableLog in to view

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 11 financial years

	2025		2024		2023		2022		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	253,9 k €	+32.4%	191,8 k €	+4.0%	184,5 k €	+1.4%	181,9 k €	+34.9%	134,9 k €	+1.1%	133,4 k €	-6.3%	142,4 k €	+14.1%	124,8 k €	+18.0%	105,7 k €	+1.8%	103,8 k €	+88.3%	55,2 k €
EBITDA	249,5 k €	+33.2%	187,3 k €	+3.6%	180,8 k €	+1.4%	178,2 k €	+35.2%	131,8 k €	+1.3%	130,1 k €	-6.9%	139,7 k €	+13.8%	122,8 k €	+17.1%	104,9 k €	+1.4%	103,4 k €	+88.6%	54,8 k €
Operating result	203,5 k €	+29.0%	157,7 k €	+9.2%	144,4 k €	+1.6%	142,1 k €	+39.7%	101,7 k €	-11.4%	114,8 k €	-7.7%	124,4 k €	+15.8%	107,4 k €	+94.0%	55,4 k €	-46.5%	103,4 k €	+92.7%	53,7 k €
Net result	134,6 k €	+28.7%	104,6 k €	+14.6%	91,3 k €	-2.5%	93,6 k €	+32.3%	70,7 k €	+0.2%	70,6 k €	-8.4%	77,1 k €	+10.5%	69,7 k €	+92.4%	36,2 k €	-48.4%	70,2 k €	-57.3%	164,5 k €
Balance sheet
Equity	1,2 M €	+13.0%	1 M €	+11.2%	929,7 k €	+10.9%	838,5 k €	+50.4%	557,5 k €	+14.5%	486,8 k €	-37.6%	779,6 k €	+11.0%	702,5 k €	+10.1%	637,8 k €	+5.1%	606,6 k €	+11.0%	546,4 k €
Total assets	1,4 M €	+4.8%	1,4 M €	+3.5%	1,3 M €	+1.1%	1,3 M €	-5.0%	1,4 M €	+4.3%	1,3 M €	+2.0%	1,3 M €	+1.2%	1,3 M €	+3.1%	1,2 M €	+35.7%	904,3 k €	+6.5%	849,2 k €
Cash	100,6 k €	+3.2%	97,5 k €	-8.6%	106,7 k €	+53.6%	69,4 k €	+0.3%	69,3 k €	+53.0%	45,3 k €	+45.2%	31,2 k €	+375%	6,6 k €	-91.9%	81,1 k €	-37.8%	130,2 k €	+209%	42,1 k €
Debts	242,3 k €	-22.9%	314 k €	-16.6%	376,7 k €	-17.0%	454 k €	-43.0%	796,2 k €	-1.9%	811,8 k €	+62.7%	499 k €	-11.0%	560,7 k €	-4.8%	589 k €	+97.8%	297,7 k €	-1.7%	302,8 k €
Other
Workforce	0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 3 ended

Active mandates

Ann Vercruysse

Director

Active

Dieter Deforce

Director

Active

Ended mandates

Dieter Deforce

Director · since 09 décembre 2020

Ended

Ann Vercruysse

Director · since 04 mai 2012

Ended

Ann Vercruysse

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Deforce KaRe● Active	1033.420.281

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/10/2025	04/10/2024	23/10/2023	29/09/2022	07/09/2021	30/09/2020
General meeting	26/09/2025	06/09/2024	01/09/2023	02/09/2022	03/09/2021	04/09/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2025	26/09/2025	17/10/2025	Dutch	PDF
Abridged model	31/03/2024	06/09/2024	04/10/2024	Dutch	PDF
Abridged model	31/03/2023	01/09/2023	23/10/2023	Dutch	PDF
Abridged model	31/03/2022	02/09/2022	29/09/2022	Dutch	PDF
Abridged model	31/03/2021	03/09/2021	07/09/2021	Dutch	PDF
Abridged model	31/03/2020	04/09/2020	30/09/2020	Dutch	PDF
Abridged model	31/03/2019	06/09/2019	30/09/2019	Dutch	PDF
Abridged model	31/03/2018	31/08/2018	01/10/2018	Dutch	PDF
Abridged model	31/03/2017	22/09/2017	31/10/2017	Dutch	PDF
Abridged model	31/03/2016	02/09/2016	20/09/2016	Dutch	PDF
Abridged model	31/03/2015	04/09/2015	22/09/2015	Dutch	PDF
Abridged model	31/03/2014	05/09/2014	29/09/2014	Dutch	PDF
Abridged model	31/03/2013	06/09/2013	25/09/2013	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 3 ended

Active mandates

Ann Vercruysse

Director

Active

Dieter Deforce

Director

Active

Ended mandates

Dieter Deforce

Director · since 09 décembre 2020

Ended

Ann Vercruysse

Director · since 04 mai 2012

Ended

Ann Vercruysse

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates07/10/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/01/2021
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Capital / shares11/12/2017
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other24/05/2012
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025134,6 k €↑
2024
Annual accounts 2024104,6 k €↑
2023
Annual accounts 202391,3 k €↓
2022
Annual accounts 202293,6 k €↑
2019
Annual accounts 201970,7 k €↑
2018
Annual accounts 201870,6 k €↓
2017
Annual accounts 201777,1 k €↑
2016
Annual accounts 201669,7 k €↑
2015
Annual accounts 201536,2 k €↓
2014
Annual accounts 201470,2 k €↓
2013
Annual accounts 2013164,5 k €
11/05/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMANN

Overview

What does PHARMANN do?

Trend over 11 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline